UBS Group’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.93M | Sell |
462,863
-89,380
| -16% | -$1.34M | ﹤0.01% | 2768 |
|
|
2025
Q1 | $8.91M | Buy |
552,243
+160,046
| +41% | +$2.58M | ﹤0.01% | 2466 |
|
|
2024
Q4 | $9.13M | Buy |
392,197
+334,359
| +578% | +$7.78M | ﹤0.01% | 2431 |
|
|
2024
Q3 | $1.7M | Buy |
57,838
+13,334
| +30% | +$392K | ﹤0.01% | 3166 |
|
|
2024
Q2 | $1.05M | Buy |
44,504
+41,903
| +1,611% | +$985K | ﹤0.01% | 3376 |
|
|
2024
Q1 | $98.7K | Sell |
2,601
-1,125
| -30% | -$42.7K | ﹤0.01% | 5079 |
|
|
2023
Q4 | $80.2K | Buy |
+3,726
| New | +$80.2K | ﹤0.01% | 5102 |
|
|
2023
Q3 | – | Sell |
-324
| Closed | -$3.65K | – | 8676 |
|
|
2023
Q2 | $3.65K | Buy |
+324
| New | +$3.65K | ﹤0.01% | 6530 |
|
|
2023
Q1 | – | Hold |
0
| – | -$4 | – | 8408 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 9416 |
|
|
2022
Q3 | – | Sell |
-3,072
| Closed | -$39K | – | 9667 |
|
|
2022
Q2 | $39K | Buy |
3,072
+461
| +18% | +$5.85K | ﹤0.01% | 5102 |
|
|
2022
Q1 | $150K | Sell |
2,611
-2,854
| -52% | -$164K | ﹤0.01% | 4603 |
|
|
2021
Q4 | $649K | Buy |
5,465
+3,296
| +152% | +$391K | ﹤0.01% | 3781 |
|
|
2021
Q3 | $431K | Buy |
2,169
+86
| +4% | +$17.1K | ﹤0.01% | 3818 |
|
|
2021
Q2 | $362K | Buy |
2,083
+84
| +4% | +$14.6K | ﹤0.01% | 3961 |
|
|
2021
Q1 | $396K | Buy |
1,999
+185
| +10% | +$36.6K | ﹤0.01% | 4094 |
|
|
2020
Q4 | $357K | Buy |
1,814
+323
| +22% | +$63.6K | ﹤0.01% | 3911 |
|
|
2020
Q3 | $264K | Sell |
1,491
-252
| -14% | -$44.6K | ﹤0.01% | 3825 |
|
|
2020
Q2 | $403K | Sell |
1,743
-18
| -1% | -$4.16K | ﹤0.01% | 3555 |
|
|
2020
Q1 | $205K | Sell |
1,761
-439
| -20% | -$51.1K | ﹤0.01% | 3878 |
|
|
2019
Q4 | $420K | Sell |
2,200
-147
| -6% | -$28.1K | ﹤0.01% | 4031 |
|
|
2019
Q3 | $451K | Buy |
2,347
+637
| +37% | +$122K | ﹤0.01% | 3804 |
|
|
2019
Q2 | $293K | Buy |
1,710
+26
| +2% | +$4.46K | ﹤0.01% | 3874 |
|
|
2019
Q1 | $339K | Sell |
1,684
-21
| -1% | -$4.23K | ﹤0.01% | 3582 |
|
|
2018
Q4 | $319K | Sell |
1,705
-422
| -20% | -$79K | ﹤0.01% | 3784 |
|
|
2018
Q3 | $509K | Sell |
2,127
-834
| -28% | -$200K | ﹤0.01% | 3618 |
|
|
2018
Q2 | $784K | Buy |
2,961
+1,978
| +201% | +$524K | ﹤0.01% | 3234 |
|
|
2018
Q1 | $244K | Buy |
983
+930
| +1,755% | +$231K | ﹤0.01% | 3870 |
|
|
2017
Q4 | $7K | Sell |
53
-25
| -32% | -$3.3K | ﹤0.01% | 6266 |
|
|
2017
Q3 | $10K | Sell |
78
-26
| -25% | -$3.33K | ﹤0.01% | 5981 |
|
|
2017
Q2 | $10K | Buy |
104
+65
| +167% | +$6.25K | ﹤0.01% | 5836 |
|
|
2017
Q1 | $7K | Buy |
39
+7
| +22% | +$1.26K | ﹤0.01% | 5902 |
|
|
2016
Q4 | $3K | Sell |
32
-663
| -95% | -$62.2K | ﹤0.01% | 6442 |
|
|
2016
Q3 | $112K | Buy |
695
+407
| +141% | +$65.6K | ﹤0.01% | 4090 |
|
|
2016
Q2 | $35K | Buy |
+288
| New | +$35K | ﹤0.01% | 4948 |
|